XtalPi Holdings Achieves Remarkable Growth with 2025 Interim Results XtalPi Holdings has reported a significant increase in revenue and profits, showcasing strong industry collaboration and innovative advancements in drug discovery.

XtalPi Holdings Achieves Remarkable Growth with 2025 Interim Results #China #Shenzhen #Drug_Discovery #XtalFold #XtalPi_Holdings

UCB and XtalPi Collaborate on Advanced AI Solutions for Biologics Discovery UCB collaborates with XtalPi's Ailux Biologics to enhance biologics drug discovery using the innovative XtalFold™ AI platform, transforming therapeutic development.

UCB and XtalPi Collaborate on Advanced AI Solutions for Biologics Discovery #USA #Cambridge #UCB #XtalPi #XtalFold